Amir H. Shojaei - 14 Aug 2026 Form 4 Insider Report for HARROW, INC. (HROW)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Aug 2026, 17:47:37 UTC
Prior SEC filing
18 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Andrew R. Boll, Attorney-in-Fact for Amir H. Shojaei

Key filing fact

Amir H. Shojaei filed Form 4 for HARROW, INC. (HROW) on 17 Aug 2026.

Key facts

  • This page summarizes Amir H. Shojaei's Form 4 filing for HARROW, INC. (HROW).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Aug 2026, 17:47.

Change

  • Previous filing in this sequence was filed on 18 May 2026.
  • Current net transaction value: -$450,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002051427 Primary reporting owner

Shojaei Amir

Relationship
CHIEF SCIENTIFIC OFFICER
Address
C/O HARROW, INC., 1A BURTON HILLS BLVD., SUITE 200, NASHVILLE
Signature
/s/ Andrew R. Boll, Attorney-in-Fact for Amir H. Shojaei
Signature date
17 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HROW transaction

Common Stock

Options Exercise

Transaction value
Shares
+11,250
Change %
Price
$35.96*
Shares after
11,250
Date
14 Aug 2026
Ownership
Direct
HROW transaction

Common Stock

Sale

Transaction value
$450,000
Shares
-11,250
Change %
-100%
Price
$40.00
Shares after
0
Date
14 Aug 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HROW transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-11,250
Change %
-38%
Price
$35.96*
Shares after
18,750
Date
14 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,250
Exercise price
$35.96
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sale reported in this Form 4 was effected as part of a broker-assisted same-day sale transaction in connection with the option exercise reported herein to fund the aggregate exercise price and related transaction costs. The Reporting Person did not retain any shares acquired upon exercise.

Footnote F2

The option was granted on January 6, 2025. The shares subject to the option vest according to the following schedule: 25% of the shares vested at the one-year anniversary of the date of grant, and the remaining shares vest over the next three years in 12 equal quarterly installments until fully vested and exercisable on January 6, 2029.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .